Item

Metabolic benefits of adding metformin to androgen deprivation therapy for patients with metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Results from the STAMPEDE metformin trial

Sachdeva, A.
; 
Gillessen, S.
; 
Murphy, L.
; 
El-Taji, O.
; 
Gray, S.
; 
Attard, G.
; 
Jones, R.
; 
Adler, A.
; 
Millman, R.
; 
Matheson, D.
... show 7 more
Citations
Altmetric:
Abstract
Authors
Sachdeva, A.
Gillessen, S.
Murphy, L.
El-Taji, O.
Gray, S.
Attard, G.
Jones, R.
Adler, A.
Millman, R.
Matheson, D.
Amos, C.
Murphy, C.
McAlpine, C.
Parmar, M.
Brown, L.
James, N. D.
Clarke, N. W.
Affiliation
Univ Manchester, Div Canc Sci, Manchester, England Christie & Salford Royal Hosp, Dept Surg, Manchester, England
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Sachdeva A, Gillessen S, Murphy L, El-Taji O, Gray S, Attard G, et al. Metabolic benefits of adding metformin to androgen deprivation therapy for patients with metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Results from the STAMPEDE metformin trial. EUROPEAN UROLOGY. 2025 MAR;87. PubMed PMID: WOS:001578797300022. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627894
Embedded videos